Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05039879
Other study ID # 2021-1814
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 6, 2021
Est. completion date December 15, 2022

Study information

Verified date February 2023
Source Wageningen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of the proposed research is to investigate the association between protein intake and nutritional status with bone health and physical functioning in older hip fracture patients. In addition, it will be investigated which patient characteristics and modifiable factors can predict mobility, clinical frailty, living situation and mortality. This study will be a 3-month prospective cohort study in adults aged 70 years and older with an acute hip fracture. This study will lead to knowledge about how protein intake and nutritional status in combination with patient characteristics can predict the degree of recovery (bone health and physical functioning) 3 months after the hip fracture. Knowledge on factors related to recovery can contribute to an improved and shorter rehabilitation in the future, which results in a reduction of health care costs.


Description:

Only half of the patients with an acute hip fracture regain their pre-fracture functional level and 24% dies within the following year. Identifying and targeting modifiable risk factors for optimal recovery after a hip fracture is therefore essential. These factors include protein intake and nutritional status, which may affect markers of bone health and physical functioning and thereby influence recovery. Measurements will be performed at baseline (within 5 days after the hip surgery) and after 3 months during an outpatient clinic visit for the evaluation of the hip fracture surgery. A total of 95 older adults (aged 70 years or older) recovering from an acute hip fracture will be recruited from Rijnstate hospital.


Recruitment information / eligibility

Status Completed
Enrollment 95
Est. completion date December 15, 2022
Est. primary completion date November 29, 2022
Accepts healthy volunteers
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria: - Age = 70 years - Community-dwelling - Proximal femur fracture: femoral neck fracture/ pertrochanteric fracture, subtrochanteric fracture - Able to give informed consent - Pre-fracture Clinical Frailty Scale 3-6 Exclusion Criteria: - Pathological fracture or periprosthetic fracture - Current participation in scientific research that interferes with the proposed study - History of dementia - No permission to request information from the general practitioner/ treating specialist(s) about medical history, medication use, liver and kidney values, and details about the broken hip

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands Rijnstate Hospital Arnhem

Sponsors (2)

Lead Sponsor Collaborator
Wageningen University Rijnstate Hospital

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Protein intake Dietary protein intake will be recorded using a protein screener which gives an indication of protein intake in g/d. Based on the past 4 weeks. Baseline
Primary Protein intake Dietary protein intake will be recorded using a protein screener which gives an indication of protein intake in g/d. Based on the past 4 weeks. Three months
Primary Nutritional status Using the Mini Nutritional Assessment Short Form. Subjects will be classified as having a normal nutritional status (12-14 points), having a risk of malnutrition (8-11 points), or being undernourished (0-7 points). Baseline
Primary Nutritional status Using the Mini Nutritional Assessment Short Form. Subjects will be classified as having a normal nutritional status (12-14 points), having a risk of malnutrition (8-11 points), or being undernourished (0-7 points). Three months
Primary Procollagen type 1 N propeptide Bone turnover marker, in serum Baseline
Primary Procollagen type 1 N propeptide Bone turnover marker, in serum Three months
Primary C-terminal telopeptide of type I collagen Bone turnover marker Baseline
Primary C-terminal telopeptide of type I collagen Bone turnover marker Three months
Primary Calcaneus quantitative ultrasound parameters Ultrasound of the calcaneus which gives an indication of the bone density. Device yields the following two parameters: speed of sound (SOS) and broadband ultrasound attenuation (BUA), which can be combined to get the Stiffness Index (SI). Baseline
Primary Calcaneus quantitative ultrasound parameters Ultrasound of the calcaneus which gives an indication of the bone density. Device yields the following two parameters: speed of sound (SOS) and broadband ultrasound attenuation (BUA), which can be combined to get the Stiffness Index (SI). Three months
Primary Insulin-like growth factor 1 In serum Baseline
Primary Insulin-like growth factor 1 In serum Three months
Primary Parathyroid hormone levels In serum Baseline
Primary Parathyroid hormone levels In serum Three months
Primary Handgrip strength Using the Martin vigorimeter Baseline
Primary Handgrip strength Using the Martin vigorimeter Three months
Primary Grip work Using the Martin vigorimeter Baseline
Primary Grip work Using the Martin vigorimeter Three months
Secondary Appendicular skeletal muscle mass Using bioimpedance spectroscopy Baseline
Secondary Appendicular skeletal muscle mass Using bioimpedance spectroscopy Three months
Secondary Mobility Pre-fracture mobility will be assessed with the pre-fracture mobility scale (PMS). The PMS classifies the patient as independent walker, walk with rollator, in a wheelchair or bedridden. Baseline
Secondary Mobility Mobility at 3 months will be assessed with the Functional Ambulation Categories (FAC). The FAC is scaled from 0 to 5, in which zero means that patient cannot walk or need at least two persons to help and five means independent walker. Three months
Secondary Frailty Frailty will be assessed with the Clinical Frailty Scale. This scale is graded from 1 to 9 in which level 1 represents 'very fit' and level 9 'terminally ill'. Baseline
Secondary Frailty Frailty will be assessed with the Clinical Frailty Scale. This scale is graded from 1 to 9 in which level 1 represents 'very fit' and level 9 'terminally ill'. Three months
Secondary Bodyweight Bodyweight (kg) will be measured with a calibrated sitting weighing scale. Baseline
Secondary Bodyweight Bodyweight (kg) will be measured with a calibrated sitting weighing scale. Three months
Secondary Barthel Index This questionnaire determines the degree of (physical or verbal) help a person needs to perform general daily activities. It is graded from 0 (person is completely dependent on others) to 20 (person is completely independent). Baseline
Secondary Barthel Index This questionnaire determines the degree of (physical or verbal) help a person needs to perform general daily activities. It is graded from 0 (person is completely dependent on others) to 20 (person is completely independent). Three months
See also
  Status Clinical Trial Phase
Completed NCT02507609 - Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium N/A
Completed NCT03906864 - Care Pathway for Sub-acute Hip Rehabilitation N/A
Recruiting NCT04063891 - Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients N/A
Not yet recruiting NCT03887494 - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY) N/A
Terminated NCT03065101 - Trigen InterTAN vs Sliding Hip Screw RCT N/A
Completed NCT03545347 - Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture. Phase 2
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05971173 - Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery Early Phase 1
Active, not recruiting NCT04957251 - Anterior vs Posterior Approach for Hip Hemiarthroplasty N/A
Terminated NCT04372966 - Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Completed NCT04424186 - 'Rehabilitation for Life' N/A
Not yet recruiting NCT04183075 - Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture N/A
Withdrawn NCT05518279 - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures Phase 3
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Active, not recruiting NCT02247791 - Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty N/A
Completed NCT00746876 - Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures. N/A
Completed NCT00058864 - The HIP Impact Protection Program (HIP PRO) N/A
Completed NCT05549011 - PENG vs SIFI Block for Positioning Pain During Spinal Anesthesia